comprehensive -WSS

comprehensive

author：leisure time 2025-10-01 00:52:29 - browse：497

Why are rich biotechs cutting costs? Has JPM Week already worn off? And what’s going to move markets in 2024?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Jason Mast joins us to discuss an emerging trend in biotech: Cash-rich startups are laying off employees and tweaking their strategies amid a tough market for venture capital. We also look ahead to the biggest biotech stories coming in 2024, including some major data readouts and a few pivotal FDA decisions.

For more on what we cover, here’s the news on Dewpoint Therapeutics; here’s more on biotech in 2024; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： The high cost of giving birth even with insurance
Next article： Pfizer's RSV vaccine recommended for approval in Europe

leisure time

WSS

Key Senate committee drafts bipartisan bill to stem drug shortages

Biden, Billy Joel, Elton John lead tributes for Tony Bennett after singer's death at 96

Biden White House, tech companies launch new safeguards around emerging AI technology

Readout Newsletter: Novavax stock, FogPharma, Novo Nordisk

What is the Turing Test that determines if computers can think?

Element Biosciences CEO lays out genome sequencing strategy

entertainment

comprehensive

explore

Trump demands the U.S. pay no more for drugs than other countries … again

Key Senate committee drafts bipartisan bill to stem drug shortages

State Dept. review finds Biden bears some blame for Afghanistan failures

Readout Newsletter: Novavax stock, FogPharma, Novo Nordisk

Bright Health sells Medicare Advantage business to Molina

Melinda French Gates resigns from Gates Foundation

Walensky prepares to leave CDC — and Congress — behind

Close Medicare's dangerous gaps in addiction treatment coverage

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Why Marc Tessier

hotspot

Orangutan used medicinal plant to treat wound, first time ever seen

BIO: Crackdown on China pharma industry would threaten U.S. drug supply

Readout Newsletter: Novavax stock, FogPharma, Novo Nordisk

More tobacco lobbyists active in statehouses

Dispute over threat of extinction posed by artificial intelligence looms over surging industry

FTC falls short on scrutinizing hospital mergers, study says

entertainment

entertainment

leisure time

Wikipedia